Snowball logo
logo
PEN_logo

Penumbra, Inc

PEN โ€ข NYSE
$324.37+$0.62ย  (0.19%)
Estimate
P/E
79.9
EPS
4.06
Beta
0.701
Growth
Revenue, YoY
14.9%
Net income, YoY
-23.1%
FCF, YoY
10.81%
Forecast
P/E (FWD)
52.9
EPS (FWD)
6.132
About the company
Ticker
PEN
ISIN
US70975L1070
Country
United States of America
Sector (GICS)
Healthcare
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Frequently asked questions

What sector does Penumbra, Inc (PEN) operate in?

Penumbra, Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Penumbra, Inc (PEN) current stock price?

As of the latest data, Penumbra, Inc stock price is $324.37, with a previous close of $323.75. Penumbra, Inc gained $0.62 in the last trading session, representing a 0.19% increase.

What is Penumbra, Inc (PEN) current market capitalization?

Penumbra, Inc market cap is approximately 12.78 billion.

What is Penumbra, Inc (PEN) Earnings Per Share (EPS)?

The trailing EPS is $4.06, and the forward EPS is $6.13.

What is Penumbra, Inc (PEN) Price-to-Earnings (P/E) ratio?

Penumbra, Inc current P/E ratio is 79.89, with a forward P/E of 52.9.

What is Penumbra, Inc (PEN) EBITDA?

Penumbra, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 52.11 million.

Does Penumbra, Inc (PEN) pay dividends?

No. Penumbra, Inc does not pay a dividend.

How did Penumbra, Inc (PEN) perform in its most recent earnings report?

In the last report (June 30, 2026), Penumbra, Inc posted an EPS surprise of -23.48% and a revenue surprise of -0.01%.

What is Penumbra, Inc (PEN) beta (volatility) score?

Penumbra, Inc has a beta of 0.701, indicating lower volatility than the overall market.